Antibodies against the β1-adrenergic receptor induce progressive development of cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 5, 2007, Pages 1001-1007

  Buvall, Lisa ^a   Täng, Margareta Scharin ^a   Isic, Azra ^a   Andersson, Bert ^a   Fu, Michael ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1 adrenergic receptor; Antibody; Cardiac function; Dilated cardiomyopathy; Immunization

Indexed keywords

ANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; COMPLEMENT COMPONENT C3; DOBUTAMINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; BETA ADRENERGIC RECEPTOR; NEPHRITIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CHEMICAL ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STRESS ECHOCARDIOGRAPHY; ANIMAL; BLOOD; BODY WEIGHT; HEART; IMMUNOLOGY; METABOLISM; METHODOLOGY; ORGAN SIZE; PATHOPHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; BODY WEIGHT; CARDIOMYOPATHY, DILATED; COMPLEMENT C3 NEPHRITIC FACTOR; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; HEART; MICE; ORGAN SIZE; RECEPTORS, ADRENERGIC, BETA;

EID: 34247583358     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.02.007     Document Type: Article

References (30)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 5 (1996 (Mar. 1)) 841-842
2. Why H.J., Archard L.C., and Richardson P.J. Dilated cardiomyopathy-New insights into the pathogenesis. Postgrad. Med. J. 70 Suppl. 1 (1994) S2-S7
3. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326 2 (1992 (Jan. 9)) 77-82
4. Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111 7 (2005 (Feb. 22)) 887-893
5. Gerli R., Rambotti P., Spinozzi F., Bertotto A., Chiodini V., Solinas P., et al. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy. Am. Heart J. 112 2 (1986(Aug.)) 350-355
6. Kanda T., Yokoyama T., Ohshima S., Yuasa K., Watanabe T., Suzuki T., et al. T-lymphocyte subsets as noninvasive markers of cardiomyopathy. Clin. Cardiol. 13 9 (1990 (Sep.)) 617-622
7. Marriott J.B., Goldman J.H., Keeling P.J., Baig M.K., Dalgleish A.G., and McKenna W.J. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 75 3 (1996 (Mar.)) 287-290
8. Magnusson Y., Wallukat G., Waagstein F., Hjalmarson A., and Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89 6 (1994 (Jun.)) 2760-2767
9. Caforio A.L., Grazzini M., Mann J.M., Keeling P.J., Bottazzo G.F., McKenna W.J., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85 5 (1992 (May)) 1734-1742
10. Ungerer M., Böhm M., Elce J.S., Erdmann E., and Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87 2 (1993 (Feb.)) 454-463
11. Koch W.J., Rockman H.A., Samama P., Hamilton R.A., Bond R.A., Milano C.A., et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268 5215 (1995 (Jun. 2)) 1350-1353
12. Magnusson Y., Marullo S., Hoyer S., Waagstein F., Andersson B., Vahlne A., et al. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 86 5 (1990 (Nov.)) 1658-1663
13. Matsui S., Fu M.L., Katsuda S., Hayase M., Yamaguchi N., Teraoka K., et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J. Mol. Cell. Cardiol. 29 2 (1997 (Feb.)) 641-655
14. Jahns R., Boivin V., Hein L., Triebel S., Angermann C.E., Ertl G., et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest. 113 10 (2004 (May)) 1419-1429
15. Scrutinio D., Napoli V., Passantino A., Ricci A., Lagioia R., and Rizzon P. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur. Heart J. 21 11 (2000 (Jun.)) 927-934
16. Buvall L., Bollano E., Chen J., Schulze W., and Fu L.X. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta1-adrenergic receptor. J. Clin. Exp. Immunol. 143 2 (2006 (Feb.)) 209-215
17. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 6 (1978 (Dec.)) 1072-1083
18. Wallukat G., and Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed. Biochim. Acta 46 8-9 (1987) S634-S639
19. Wallukat G., Wollenberger A., Morwinski R., and Pitschner H.F. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J. Mol. Cell. Cardiol. 27 1 (1995 (Jan.)) 397-406
20. Staudt Y., Mobini R., Fu M., Felix S.B., Kuhn J.P., and Staudt A. Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur. J. Pharmacol. 466 1-2 (2003 (Apr. 11)) 1-6
21. Gimenez L.E., Hernandez C.C., Mattos E.C., Brandao I.T., Olivieri B., Campelo R.P., et al. DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice. J. Mol. Cell. Cardiol. 38 5 (2005 (May)) 703-714
22. Jahns R., Boivin V., Krapf T., Wallukat G., Boege F., and Lohse M.J. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J. Am. Coll. Cardiol. 36 4 (2000 (Oct.)) 1280-1287
23. Hoebeke J. Molecular mechanisms of anti-G-protein-coupled receptor autoantibodies. Autoimmunity 34 3 (2001) 161-164
24. Seko Y., Takahashi N., Ishiyama S., Nishikawa T., Kasajima T., Hiroe M., et al. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 97 7 (1998 (Feb. 24)) 637-639
25. Klimiuk P.A., Sierakowski S., Latosiewicz R., Skowronski J., Cylwik J.P., Cylwik B., et al. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J. Rheumatol. 32 9 (2005 (Sep.)) 1666-1672
26. Liu S.H., Wong C.S., and Chang D.M. Increased monocyte chemoattractant protein-1 in knee joints of rats with adjuvant-induced arthritis: in vivo microdialysis. J. Rheumatol. 32 11 (2005 (Nov.)) 2205-2211
27. Deo R., Khera A., McGuire D.K., Murphy S.A., Meo Neto Jde P., Morrow D.A., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 44 9 (2004 (Nov. 2)) 1812-1818
28. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 6871 (2002 (Jan. 31)) 536-541
29. Clark D.J., Cleman M.W., Pfau S.E., Rollins S.A., Ramahi T.M., Mayer C., et al. Serum complement activation in congestive heart failure. Am. Heart J. 141 4 (2001 (Apr.)) 684-690
30. Latif N., Smith J., Dunn M.J., Yacoub M.H., and Rose M.L. Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy. Autoimmunity 19 2 (1994) 99-104